KAAACI Allergic Rhinitis Guidelines: Part 1. Update in Pharmacotherapy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yang, Song -, I | - |
dc.contributor.author | Lee, Il Hwan | - |
dc.contributor.author | Kim, Minji | - |
dc.contributor.author | Ryu, Gwanghui | - |
dc.contributor.author | Kang, Sung-Yoon | - |
dc.contributor.author | Kim, Mi-Ae | - |
dc.contributor.author | Lee, Sang Min | - |
dc.contributor.author | Kim, Hyun-Jung | - |
dc.contributor.author | Park, Do -Yang | - |
dc.contributor.author | Lee, Yong Ju | - |
dc.contributor.author | Kim, Dong-Kyu | - |
dc.contributor.author | Kim, Soo Whan | - |
dc.contributor.author | Kim, Do Hyun | - |
dc.contributor.author | Jun, Young Joon | - |
dc.contributor.author | Park, Sang Chul | - |
dc.contributor.author | Kim, Bong-Seong | - |
dc.contributor.author | Chung, Soo Jie | - |
dc.contributor.author | Lee, Hyun Jong | - |
dc.contributor.author | Kim, Hyo-Bin | - |
dc.contributor.author | Choi, Jeong-Hee | - |
dc.contributor.author | Choi, Gil-Soon | - |
dc.contributor.author | Yang, Hyeon-Jong | - |
dc.date.accessioned | 2023-03-03T09:40:05Z | - |
dc.date.available | 2023-03-03T09:40:05Z | - |
dc.date.created | 2023-03-03 | - |
dc.date.issued | 2023-01 | - |
dc.identifier.issn | 2092-7355 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/86976 | - |
dc.description.abstract | The prevalence of allergic rhinitis (AR) and the socioeconomic burden associated with the medical cost and quality of life (QOL) of AR have progressively increased. Therefore, practical guidelines for the appropriate management of AR need to be developed based on scientific evidence while considering the real-world environment, values, and preferences of patients and physicians. The Korean Academy of Asthma, Allergy and Clinical Immunology revised clinical guidelines of AR to address key clinical questions of the management of AR. Part 1 of the revised guideline covers the pharmacological management of patients with AR in Korea. Through a meta-analysis and systematic review, we made 4 recommendations for AR pharmacotherapy, including intranasal corticosteroid (INCS)/intranasal antihistamine (INAH) combination therapy, oral antihistamine/INCS combination therapy, leukotriene receptor antagonist treatment in AR patients with asthma, and prophylactic treatment for patients with pollen-induced AR. However, all recommendations are conditional because of the low or very low evidence of certainty. Well-designed and strictly executed randomized controlled trials are needed to measure and report appropriate outcomes. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN ACAD ASTHMA ALLERGY & CLINICAL IMMUNOLOGY | - |
dc.relation.isPartOf | ALLERGY ASTHMA & IMMUNOLOGY RESEARCH | - |
dc.title | KAAACI Allergic Rhinitis Guidelines: Part 1. Update in Pharmacotherapy | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000924635300004 | - |
dc.identifier.doi | 10.4168/aair.2023.15.1.19 | - |
dc.identifier.bibliographicCitation | ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, v.15, no.1, pp.19 - 31 | - |
dc.identifier.kciid | ART002926512 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.scopusid | 2-s2.0-85147379280 | - |
dc.citation.endPage | 31 | - |
dc.citation.startPage | 19 | - |
dc.citation.title | ALLERGY ASTHMA & IMMUNOLOGY RESEARCH | - |
dc.citation.volume | 15 | - |
dc.citation.number | 1 | - |
dc.contributor.affiliatedAuthor | Kang, Sung-Yoon | - |
dc.contributor.affiliatedAuthor | Lee, Sang Min | - |
dc.type.docType | Review | - |
dc.subject.keywordAuthor | Rhinitis | - |
dc.subject.keywordAuthor | allergic | - |
dc.subject.keywordAuthor | asthma | - |
dc.subject.keywordAuthor | guideline | - |
dc.subject.keywordAuthor | drug therapy | - |
dc.subject.keywordPlus | ADD-ON THERAPY | - |
dc.subject.keywordPlus | PROPIONATE NASAL SPRAY | - |
dc.subject.keywordPlus | MOMETASONE FUROATE | - |
dc.subject.keywordPlus | PROPHYLACTIC TREATMENT | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordPlus | AZELASTINE HYDROCHLORIDE | - |
dc.subject.keywordPlus | COMBINATION TREATMENT | - |
dc.subject.keywordPlus | TOPICAL TREATMENT | - |
dc.subject.keywordPlus | PLUS CETIRIZINE | - |
dc.subject.keywordPlus | FLUTICASONE | - |
dc.relation.journalResearchArea | Allergy | - |
dc.relation.journalResearchArea | Immunology | - |
dc.relation.journalWebOfScienceCategory | Allergy | - |
dc.relation.journalWebOfScienceCategory | Immunology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.